Income Statement Thales

Stocks

HO

FR0000121329

Aerospace & Defense

Market Closed - Euronext Paris Other stock markets 11:55:00 2026-07-13 am EDT			5-day change	1st Jan Change
221.10 ^EUR	-0.99%		-8.30%	-3.79%

Jul. 13	Morgan Stanley Reduces Thales PT, Keeps at Equalweight	MT
Jul. 13	Thales to modernize air traffic management infrastructure in Mongolia

8a14ae.JZ1vsEfVdVwTx5ozJeXveOwZUKIB21fTLNnWPxLh68c.cdw56jasNjkivt19f5OIH6thEfZoqDGfVbaac3-FiLdXxAjldOQmLXSi8Q

Published financial data: THALES

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	16.19B	17.57B	18.43B	20.58B	22.14B
Total Revenues	16.19B	17.57B	18.43B	20.58B	22.14B
Cost of Goods Sold, Total	12.16B	13.06B	13.66B	15.2B	16.28B
Gross Profit	4.03B	4.51B	4.77B	5.37B	5.85B
Selling General & Admin Expenses, Total	1.79B	1.95B	2.08B	2.33B	2.35B
R&D Expenses	1.03B	1.06B	1.11B	1.27B	1.33B
Amortization of Goodwill and Intangible Assets - (IS)	-	-	-	-	-
Other Operating Expenses	-	-	-	-	-500K
Other Operating Expenses, Total	2.82B	3.02B	3.19B	3.61B	3.68B
Operating Income	1.21B	1.49B	1.58B	1.77B	2.18B
Interest Expense, Total	-54.1M	-75.9M	-160M	-289M	-233M
Interest And Investment Income	-	25.8M	161M	124M	117M
Net Interest Expenses	-54.1M	-50.1M	1.8M	-166M	-116M
Income (Loss) On Equity Invest.	104M	180M	147M	95.1M	198M
Currency Exchange Gains (Loss)	-6.9M	-27.7M	-26M	-1.7M	-31.2M
Other Non Operating Income (Expenses)	-48.4M	-70.8M	-39M	41.1M	-34.6M
EBT, Excl. Unusual Items	1.21B	1.52B	1.66B	1.73B	2.19B
Restructuring Charges	-91.8M	-98.5M	-91.4M	-118M	-132M
Merger & Related Restructuring Charges	-9.1M	-17.3M	-60.4M	-18.7M	-34.1M
Impairment of Goodwill	-	-	-	-	-
Gain (Loss) On Sale Of Investments	6.4M	-13.7M	85.5M	-800K	-3.2M
Gain (Loss) On Sale Of Assets	-2.2M	-1.5M	-6.3M	1.7M	-
Asset Writedown	-	-	-	-158M	-
Legal Settlements	49.2M	38M	-3.8M	-	-
Other Unusual Items	4.4M	-81.1M	-403M	-261M	14.2M
EBT, Incl. Unusual Items	1.16B	1.35B	1.18B	1.18B	2.04B
Income Tax Expense	148M	225M	252M	247M	396M
Earnings From Continuing Operations	1.02B	1.12B	929M	932M	1.64B
Earnings Of Discontinued Operations	118M	9.1M	74.3M	412M	-
Net Income to Company	1.13B	1.13B	1B	1.34B	1.64B
Minority Interest	-45.6M	-10.4M	20.5M	75.1M	34.2M
Net Income - (IS)	1.09B	1.12B	1.02B	1.42B	1.67B
Net Income to Common Incl Extra Items	1.09B	1.12B	1.02B	1.42B	1.67B
Net Income to Common Excl. Extra Items	971M	1.11B	949M	1.01B	1.67B
Per Share Items
Net EPS - Basic	5.12	5.29	4.91	6.91	8.15
Basic EPS - Continuing Operations	4.56	5.25	4.55	4.9	8.15
Basic Weighted Average Shares Outstanding	213M	212M	209M	206M	205M
Net EPS - Diluted	5.11	5.27	4.9	6.89	8.13
Diluted EPS - Continuing Operations	4.56	5.23	4.54	4.89	8.13
Diluted Weighted Average Shares Outstanding	213M	212M	209M	206M	206M
Normalized Basic EPS	3.33	4.44	5.07	5.64	6.83
Normalized Diluted EPS	3.33	4.43	5.06	5.63	6.82
Dividend Per Share	2.56	2.94	3.4	3.7	3.9
Payout Ratio	38.3	50.28	61.92	49.9	46.62
American Depositary Receipts Ratio (ADR)	0.2	0.2	0.2	0.2	0.2
Supplemental Items
EBITDA	2.05B	2.32B	2.39B	2.69B	3.01B
EBITA	1.63B	1.91B	1.99B	2.27B	2.59B
EBIT	1.21B	1.49B	1.58B	1.77B	2.18B
Effective Tax Rate - (Ratio)	12.68	16.71	21.36	20.96	19.47
Total Current Taxes	304M	349M	401M	442M	510M
Total Deferred Taxes	-156M	-124M	-149M	-195M	-114M
Normalized Net Income	709M	940M	1.06B	1.16B	1.4B
Interest on Long-Term Debt	22.6M	26.3M	31M	35.6M	36M
Non-Cash Pension Expense	17.6M	34.3M	481M	124M	29.8M
Supplemental Operating Expense Items
Selling and Marketing Expenses	1.23B	1.35B	1.38B	1.59B	1.58B
General and Administrative Expenses	545M	598M	621M	693M	725M
Research And Development Expense From Footnotes	1.05B	1.08B	1.13B	1.29B	1.35B
Stock-Based Comp., Other (Total)	39.4M	57.1M	53.3M	93.6M	112M
Total Stock-Based Compensation	39.4M	57.1M	53.3M	93.6M	112M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	5.05B	5.1B	3.98B	4.77B	4.45B
Short Term Investments	-	200M	101M	900K	44.6M
Trading Asset Securities, Total	-	3.2M	-	200K	-
Total Cash And Short Term Investments	5.05B	5.3B	4.08B	4.77B	4.49B
Accounts Receivable, Total	6.01B	6.06B	6.76B	7.67B	7.52B
Other Receivables	2.13B	2.37B	2.61B	2.89B	3.2B
Notes Receivable	-	-	-	-	104M
Total Receivables	8.14B	8.44B	9.37B	10.56B	10.83B
Inventory	3.09B	3.4B	4B	4.75B	4.83B
Other Current Assets, Total	3.43B	3.87B	4.21B	1.22B	1.17B
Total Current Assets	19.7B	21.01B	21.66B	21.3B	21.32B
Gross Property Plant And Equipment	9.13B	9.5B	9.95B	10.63B	10.99B
Accumulated Depreciation	-5.73B	-6.02B	-6.35B	-6.92B	-7.1B
Net Property Plant And Equipment	3.4B	3.48B	3.6B	3.72B	3.9B
Long-term Investments	1.48B	1.72B	1.78B	1.81B	1.85B
Goodwill	5.2B	5.47B	8.94B	8.9B	8.53B
Other Intangibles, Total	1.92B	1.53B	1.25B	2.49B	1.95B
Loans Receivable Long-Term	151M	133M	154M	167M	139M
Deferred Tax Assets Long-Term	949M	1.04B	1.18B	1.37B	1.28B
Deferred Charges Long-Term	35.3M	40.6M	42M	42.3M	41.8M
Other Long-Term Assets, Total	-	-	190M	205M	138M
Total Assets	32.84B	34.42B	38.79B	39.99B	39.16B
Liabilities
Accounts Payable, Total	2.07B	2.51B	2.74B	3.01B	2.95B
Accrued Expenses, Total	3.26B	3.66B	4.13B	4.45B	4.69B
Short-term Borrowings	1.11B	1.27B	2.5B	3.04B	1.91B
Current Portion of Long-Term Debt	-	4.6M	1M	-	-
Current Portion of Leases	208M	208M	215M	228M	223M
Current Income Taxes Payable	141M	168M	220M	193M	242M
Unearned Revenue Current, Total	7.07B	8.31B	9.79B	11.54B	12.38B
Other Current Liabilities	4.71B	4.61B	4.63B	3.19B	2.84B
Total Current Liabilities	18.57B	20.74B	24.22B	25.66B	25.24B
Long-Term Debt	3.3B	2.69B	4.48B	3.39B	2.89B
Long-Term Leases	1.31B	1.3B	1.24B	1.16B	1.11B
Pension & Other Post Retirement Benefits	2.45B	1.91B	1.55B	1.59B	1.42B
Deferred Tax Liability Non Current	491M	397M	319M	635M	510M
Total Liabilities	26.12B	27.04B	31.82B	32.43B	31.17B
Common Stock, Total	640M	640M	631M	618M	618M
Additional Paid In Capital	4.08B	4.08B	3.71B	3.13B	3.13B
Retained Earnings	2.12B	3.22B	3.37B	4.08B	5B
Treasury Stock	-37.7M	-382M	-476M	-92.5M	-90.5M
Comprehensive Income and Other	-322M	-383M	-402M	-222M	-693M
Total Common Equity	6.48B	7.17B	6.83B	7.52B	7.97B
Minority Interest	244M	208M	139M	42.9M	19.3M
Total Equity	6.72B	7.38B	6.97B	7.56B	7.99B
Total Liabilities And Equity	32.84B	34.42B	38.79B	39.99B	39.16B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	213M	210M	207M	205M	205M
ECS Total Common Shares Outstanding	213M	210M	207M	205M	205M
Book Value / Share	30.43	34.14	33.05	36.6	38.78
Tangible Book Value	-638M	179M	-3.36B	-3.87B	-2.52B
Tangible Book Value Per Share	-3	0.85	-16.24	-18.87	-12.25
Total Debt	5.93B	5.48B	8.43B	7.82B	6.13B
Net Debt	879M	174M	4.35B	3.06B	1.64B
Debt Equivalent of Unfunded Proj. Benefit Obligation	2.45B	1.85B	1.55B	1.59B	1.4B
Minority Interest, Total (Incl. Fin. Div)	244M	208M	139M	42.9M	19.3M
Equity Method Investments, Total	1.34B	1.59B	1.65B	1.65B	1.71B
Account Code - Inventory Valuation	3	3	3	3	3
Inventories - Raw Materials, Total	977M	1.12B	1.32B	1.54B	1.65B
Inventories - Work In Process, Total	2.8B	2.96B	3.34B	3.81B	3.82B
Inventories - Finished Goods, Total	66.9M	58.7M	62.7M	59.4M	66.6M
Land - (BS)	57.6M	57.2M	65M	65.3M	184M
Buildings, Total	2.23B	2.27B	2.36B	2.59B	2.68B
Full Time Employees	76.14K	80.14K	76.3K	78.19K	79.26K
Part Time Employees	4.86K	5.12K	4.6K	4.83K	5.7K
Accumulated Allowance for Doubtful Accounts (Supple)	131M	142M	138M	131M	145M
Order Backlog	34.74B	40.96B	45.25B	50.6B	53.32B

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	1.09B	1.12B	1.02B	1.42B	1.67B
Depreciation & Amortization - CF	628M	619M	612M	627M	658M
Amortization of Goodwill and Intangible Assets - (CF)	415M	421M	413M	507M	410M
Depreciation & Amortization, Total	1.04B	1.04B	1.02B	1.13B	1.07B
Amortization of Deferred Charges, Total - (CF)	19.8M	18.9M	20.2M	20.8M	18.4M
(Gain) Loss From Sale Of Asset	2.2M	1.5M	6.3M	-1.7M	-500K
(Gain) Loss on Sale of Investments - (CF)	-6.4M	13.7M	-85.5M	800K	3.2M
Asset Writedown & Restructuring Costs	-54.1M	-52.1M	-15.6M	176M	15.9M
(Income) Loss On Equity Investments - (CF)	-104M	-180M	-147M	-95.1M	-198M
Net Cash From Discontinued Operations	126M	-165M	85M	-109M	-
Other Operating Activities, Total	-58.9M	96.5M	-488M	65.4M	16.3M
Change In Accounts Receivable	-1.06B	-273M	-967M	-1.23B	-700M
Change In Inventories	75.2M	-569M	-819M	-773M	-157M
Change In Accounts Payable	364M	524M	714M	360M	269M
Change in Unearned Revenues	1.17B	1.19B	1.27B	1.71B	1.5B
Change in Other Net Operating Assets	220M	94M	-20.8M	-42M	-190M
Cash from Operations	2.83B	2.86B	1.6B	2.64B	3.32B
Capital Expenditure	-381M	-470M	-540M	-540M	-687M
Sale of Property, Plant, and Equipment	4.9M	8.5M	3.9M	6.2M	10.4M
Cash Acquisitions	-54.7M	-418M	-3.58B	-1.17B	-9.2M
Divestitures	2.2M	28.9M	152M	1.52B	-76.9M
Sale (Purchase) of Intangible assets	-69.6M	-64.4M	-85.4M	-83.3M	-69.6M
Investment in Marketable and Equity Securities, Total	19.2M	-213M	-80.9M	102M	-142M
Net (Increase) Decrease in Loans Originated / Sold - Investing	-14.2M	-3.9M	-18.5M	-6.3M	64.7M
Other Investing Activities, Total	-	-	-86M	108M	-
Cash from Investing	-493M	-1.13B	-4.23B	-62.8M	-910M
Long-Term Debt Issued, Total	51.1M	90.7M	3.65B	158M	51.1M
Total Debt Issued	51.1M	90.7M	3.65B	158M	51.1M
Long-Term Debt Repaid, Total	-1.76B	-787M	-909M	-1.16B	-1.88B
Total Debt Repaid	-1.76B	-787M	-909M	-1.16B	-1.88B
Issuance of Common Stock	-	-	-	-	-
Repurchase of Common Stock	-26.7M	-351M	-491M	-275M	-45.2M
Common Dividends Paid	-417M	-563M	-634M	-708M	-781M
Common & Preferred Stock Dividends Paid	-417M	-563M	-634M	-708M	-781M
Other Financing Activities, Total	-13.5M	-41.7M	-30.2M	-21.6M	-2.2M
Cash from Financing	-2.17B	-1.65B	1.59B	-2B	-2.66B
Foreign Exchange Rate Adjustments	41.8M	2.7M	-43.7M	-12.9M	-76.5M
Net Change in Cash	212M	80M	-1.09B	560M	-321M
Supplemental Items
Cash Interest Paid	64.8M	69M	148M	267M	226M
Cash Income Tax Paid (Refund)	145M	156M	195M	185M	413M
Levered Free Cash Flow	1.61B	2.42B	1.74B	3.47B	2.08B
Unlevered Free Cash Flow	1.64B	2.47B	1.84B	3.65B	2.22B
Change In Net Working Capital	-230M	-953M	-386M	-1.92B	-420M
Net Debt Issued / Repaid	-1.71B	-696M	2.75B	-997M	-1.83B

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	2.35	2.77	2.69	2.8	3.44
Return on Total Capital	5.92	7.3	6.97	7.17	9.22
Return On Equity %	16.86	15.91	12.94	12.84	21.1
Return on Common Equity	16.71	16.29	13.55	14.05	21.63
Margin Analysis
Gross Profit Margin %	24.91	25.65	25.86	26.12	26.44
SG&A Margin	11.07	11.12	11.3	11.35	10.62
EBITDA Margin %	12.66	13.22	12.95	13.08	13.6
EBITA Margin %	10.06	10.87	10.79	11.05	11.68
EBIT Margin %	7.49	8.48	8.55	8.58	9.83
Income From Continuing Operations Margin %	6.28	6.39	5.04	4.53	7.41
Net Income Margin %	6.72	6.38	5.55	6.9	7.56
Net Avail. For Common Margin %	6	6.33	5.15	4.9	7.56
Normalized Net Income Margin	4.38	5.35	5.74	5.63	6.34
Levered Free Cash Flow Margin	9.92	13.77	9.47	16.87	9.38
Unlevered Free Cash Flow Margin	10.13	14.04	10.01	17.75	10.04
Asset Turnover
Asset Turnover	0.5	0.52	0.5	0.52	0.56
Fixed Assets Turnover	4.65	5.11	5.21	5.63	5.81
Receivables Turnover (Average Receivables)	2.64	2.91	2.87	2.85	2.91
Inventory Turnover (Average Inventory)	3.79	4.03	3.69	3.48	3.4
Short Term Liquidity
Current Ratio	1.06	1.01	0.89	0.83	0.84
Quick Ratio	0.71	0.66	0.56	0.6	0.6
Operating Cash Flow to Current Liabilities	0.15	0.14	0.07	0.1	0.13
Days Sales Outstanding (Average Receivables)	138.22	125.42	127.03	128.35	125.29
Days Outstanding Inventory (Average Inventory)	96.4	90.68	98.83	105.26	107.39
Average Days Payable Outstanding	65.63	62.45	67.18	65.95	66.46
Cash Conversion Cycle (Average Days)	168.99	153.65	158.67	167.65	166.22
Long Term Solvency
Total Debt/Equity	88.17	74.2	121.03	103.51	76.74
Total Debt / Total Capital	46.86	42.59	54.76	50.86	43.42
LT Debt/Equity	68.55	54.08	82.08	60.21	50.07
Long-Term Debt / Total Capital	36.43	31.05	37.14	29.59	28.33
Total Liabilities / Total Assets	79.52	78.55	82.03	81.1	79.6
EBIT / Interest Expense	22.43	19.63	9.87	6.1	9.35
EBITDA / Interest Expense	41.7	33.33	16.3	10.03	13.94
(EBITDA - Capex) / Interest Expense	34.66	27.14	12.91	8.16	10.99
Total Debt / EBITDA	2.63	2.17	3.24	2.7	1.89
Net Debt / EBITDA	0.39	0.07	1.67	1.05	0.51
Total Debt / (EBITDA - Capex)	3.16	2.66	4.09	3.31	2.4
Net Debt / (EBITDA - Capex)	0.47	0.08	2.11	1.29	0.64
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	5.34	8.5	4.89	11.66	7.58
Gross Profit, 1 Yr. Growth %	12.66	11.75	6.98	12.75	8.92
EBITDA, 1 Yr. Growth %	18.61	13.24	5.1	12.76	11.88
EBITA, 1 Yr. Growth %	23.38	17.3	7.02	14.27	13.76
EBIT, 1 Yr. Growth %	41.45	22.77	9.59	12.04	23.19
Earnings From Cont. Operations, 1 Yr. Growth %	126.16	10.34	-17.23	0.4	75.94
Net Income, 1 Yr. Growth %	125.24	2.92	-8.67	38.7	17.96
Normalized Net Income, 1 Yr. Growth %	49.97	32.59	16.53	9.55	21.14
Diluted EPS Before Extra, 1 Yr. Growth %	120.06	14.69	-13.19	7.71	66.26
Accounts Receivable, 1 Yr. Growth %	-3.87	0.87	11.56	13.35	-1.94
Inventory, 1 Yr. Growth %	-7.36	10.13	17.51	18.77	1.83
Net Property, Plant and Equip., 1 Yr. Growth %	-4.79	2.35	3.37	3.32	4.94
Total Assets, 1 Yr. Growth %	3.27	4.83	12.68	3.1	-2.09
Tangible Book Value, 1 Yr. Growth %	-79.57	-128.08	-1.98K	15.46	-35.05
Common Equity, 1 Yr. Growth %	26.01	10.81	-4.79	10.03	6.03
Cash From Operations, 1 Yr. Growth %	141.99	0.97	-46.69	65.23	25.93
Capital Expenditures, 1 Yr. Growth %	22.97	23.16	15.02	-0.06	27.31
Levered Free Cash Flow, 1 Yr. Growth %	53.54	50.57	-26.9	99.06	-40.19
Unlevered Free Cash Flow, 1 Yr. Growth %	51.15	50.36	-24.22	98.1	-39.16
Dividend Per Share, 1 Yr. Growth %	45.45	14.84	15.65	8.82	5.41
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-6.19	6.91	6.68	8.22	9.6
Gross Profit, 2 Yr. CAGR %	-5.58	12.21	8.71	9.82	10.82
EBITDA, 2 Yr. CAGR %	-3.29	15.89	7.87	8.87	12.32
EBITA, 2 Yr. CAGR %	-4.25	20.3	10.52	10.59	14.01
EBIT, 2 Yr. CAGR %	-4.72	31.78	13.96	10.81	17.49
Earnings From Cont. Operations, 2 Yr. CAGR %	-5.82	57.97	-4.44	-8.84	32.91
Net Income, 2 Yr. CAGR %	-1.49	52.26	-3.05	12.55	27.91
Normalized Net Income, 2 Yr. CAGR %	-7	41.01	22.15	12.99	15.2
Diluted EPS Before Extra, 2 Yr. CAGR %	-6.91	58.9	-0.22	-3.31	33.82
Accounts Receivable, 2 Yr. CAGR %	-4.63	-1.53	6.08	12.45	5.47
Inventory, 2 Yr. CAGR %	-6.79	1.01	13.76	18.14	9.98
Net Property, Plant and Equip., 2 Yr. CAGR %	-5.8	-1.28	2.86	3.34	4.13
Total Assets, 2 Yr. CAGR %	2.56	4.04	8.68	7.79	0.48
Tangible Book Value, 2 Yr. CAGR %	-55.91	-76.09	129.61	365.63	-13.4
Common Equity, 2 Yr. CAGR %	9.05	18.11	2.71	2.35	8.01
Cash From Operations, 2 Yr. CAGR %	26.51	56.32	-24.94	-6.15	44.25
Capital Expenditures, 2 Yr. CAGR %	-3.32	23.07	19.02	7.22	12.8
Levered Free Cash Flow, 2 Yr. CAGR %	39.89	52.06	4.21	20.63	9.12
Unlevered Free Cash Flow, 2 Yr. CAGR %	38.08	50.76	6.04	22.52	9.78
Dividend Per Share, 2 Yr. CAGR %	106.56	29.25	15.24	12.18	7.1
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	0.7	-1.53	6.23	8.32	8.01
Gross Profit, 3 Yr. CAGR %	0.4	-0.12	10.01	10.04	9.52
EBITDA, 3 Yr. CAGR %	2.93	1.93	11.34	9.48	9.86
EBITA, 3 Yr. CAGR %	1.35	2.45	14.65	11.75	11.63
EBIT, 3 Yr. CAGR %	-4.92	3.68	22.48	13.32	14.79
Earnings From Cont. Operations, 3 Yr. CAGR %	-0.36	-0.72	27.35	-2.85	13.5
Net Income, 3 Yr. CAGR %	3.51	-0.04	28.4	9.24	14.33
Normalized Net Income, 3 Yr. CAGR %	-6.9	4.67	30.79	17.8	15.64
Diluted EPS Before Extra, 3 Yr. CAGR %	-0.3	-0.19	29.9	2.36	15.84
Accounts Receivable, 3 Yr. CAGR %	-5.9	-2.83	2.65	8.45	7.46
Inventory, 3 Yr. CAGR %	1.76	-1.46	6.23	15.41	12.43
Net Property, Plant and Equip., 3 Yr. CAGR %	23.4	-3.16	0.24	3.01	3.88
Total Assets, 3 Yr. CAGR %	8.79	3.3	6.84	6.79	4.39
Tangible Book Value, 3 Yr. CAGR %	-25.04	-62.11	2.41	82.59	141.48
Common Equity, 3 Yr. CAGR %	4.37	9.6	9.92	5.1	3.56
Cash From Operations, 3 Yr. CAGR %	37.38	17.35	10.89	-2.35	3.51
Capital Expenditures, 3 Yr. CAGR %	5.59	4.81	20.32	12.29	13.53
Levered Free Cash Flow, 3 Yr. CAGR %	32.07	43.37	18.59	29.3	-4.52
Unlevered Free Cash Flow, 3 Yr. CAGR %	31.95	42.06	19.34	30.6	-2.98
Dividend Per Share, 3 Yr. CAGR %	7.17	69.85	24.54	13.06	9.88
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	1.7	2.9	3.05	2.26	7.57
Gross Profit, 5 Yr. CAGR %	2.25	3.96	3.64	3.5	10.33
EBITDA, 5 Yr. CAGR %	5.3	7.76	4.88	4.18	11.73
EBITA, 5 Yr. CAGR %	4.82	8.29	4.92	5.05	14.39
EBIT, 5 Yr. CAGR %	1.25	5.7	2.22	5.72	20.45
Earnings From Cont. Operations, 5 Yr. CAGR %	0.04	8.76	-2.01	-4.05	29.54
Net Income, 5 Yr. CAGR %	2.84	10.51	0.83	4.82	28.21
Normalized Net Income, 5 Yr. CAGR %	1.03	7.2	3.78	7.17	24.32
Diluted EPS Before Extra, 5 Yr. CAGR %	0.53	10.39	-0.26	-1.45	31.45
Accounts Receivable, 5 Yr. CAGR %	1.42	3.78	-1.28	3.02	3.77
Inventory, 5 Yr. CAGR %	2.46	2.2	6.4	5.96	7.71
Net Property, Plant and Equip., 5 Yr. CAGR %	13.57	13.84	14.73	-0.61	1.78
Total Assets, 5 Yr. CAGR %	7.68	7.98	8.74	5.07	4.25
Tangible Book Value, 5 Yr. CAGR %	13.69	-22.6	17.23	3.36	-4.24
Common Equity, 5 Yr. CAGR %	6.91	7.83	3.68	6.64	9.15
Cash From Operations, 5 Yr. CAGR %	16.19	10.8	7.88	8.3	23.19
Capital Expenditures, 5 Yr. CAGR %	-2.32	4.71	10.77	5.76	17.26
Levered Free Cash Flow, 5 Yr. CAGR %	12.59	12.61	20.13	33.44	14.7
Unlevered Free Cash Flow, 5 Yr. CAGR %	12.89	12.88	20.91	33.54	15.42
Dividend Per Share, 5 Yr. CAGR %	9.86	10.93	10.33	43.88	17.25